Endoglin (CD105) Silencing Mediated by shRNA Under the Control of Endothelin-1 Promoter for Targeted Gene Therapy of Melanoma: Molecular Therapy - Nucleic Acids
The subpopulation of CD105 negative mesenchymal stem cells show strong immunomodulation capacity compared to CD105 positive mesenchymal stem cells | Biomedical Research and Therapy
FITC Mouse anti-Human CD105
Alpine CDA-105 CD receiver at Crutchfield
Endoglin/CD105 Protein Overview: Sequence, Structure, Function and Protein Interaction | Sino Biological
Anti-CD105 antibody [MEM-226] KO Tested (ab2529) | Abcam